RxDoctor Payments DataLook up a doctor →

Karen Moses

Adult Health · Savannah, GANPI 1093999054

Payments from drug & device makers

$11,473in general payments, 2019–2025

Across 508 payments — averaging $22.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$923
  • Johnson & Johnson$682
  • Merck$660
  • Novartis$619
  • Astellas Pharma US Inc$495
  • Amgen$490
  • plus $8K from 50 others

What the payments were for

  • Food & beverage$10,75594%
  • Education$7186%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,473 in reported general payments places this provider in the 95th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide18$329,861
SprycelDasatinib13$235,324
EliquisApixaban18$18,139
Letrozole17$465
Anastrozole41$376
Ondansetron OdtOndansetron19$359
Dexamethasone16$285
Promethazine Hcl18$156

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bristol Myers SquibbRevlimid$460$329,86118 claims
E.r. Squibb & Sons, L.L.C.Sprycel$434$235,32413 claims
PfizerEliquis$473$18,13918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 577 adult health providers in Georgia.

Other adult health in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →